• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种发育调控剪接变体的致癌作用。

Oncogenic role of a developmentally regulated splice variant.

作者信息

Pattwell Siobhan S, Arora Sonali, Nuechterlein Nicholas, Zager Michael, Loeb Keith R, Cimino Patrick J, Holland Nikolas C, Reche-Ley Noemi, Bolouri Hamid, Almiron Bonnin Damian A, Szulzewsky Frank, Phadnis Vaishnavi V, Ozawa Tatsuya, Wagner Michael J, Haffner Michael C, Cao Junyue, Shendure Jay, Holland Eric C

机构信息

Human Biology Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Mailstop C3-168, Seattle, WA 98109, USA.

Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA 98101, USA.

出版信息

Sci Adv. 2022 Oct 7;8(40):eabo6789. doi: 10.1126/sciadv.abo6789.

DOI:10.1126/sciadv.abo6789
PMID:36206341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9544329/
Abstract

Temporally regulated alternative splicing choices are vital for proper development, yet the wrong splice choice may be detrimental. Here, we highlight a previously unidentified role for the neurotrophin receptor splice variant TrkB.T1 in neurodevelopment, embryogenesis, transformation, and oncogenesis across multiple tumor types in humans and mice. TrkB.T1 is the predominant isoform across embryonic organogenesis, and forced overexpression of this embryonic pattern causes multiple solid and nonsolid tumors in mice in the context of tumor suppressor loss. TrkB.T1 also emerges as the predominant isoform expressed in a wide range of adult and pediatric tumors, including those harboring tropomyosin receptor kinase fusions. Affinity purification-mass spectrometry proteomic analysis reveals distinct interactors with known developmental and oncogenic signaling pathways such as Wnt, transforming growth factor-β, Sonic Hedgehog, and Ras. From alterations in splicing factors to changes in gene expression, the discovery of isoform specific oncogenes with embryonic ancestry has the potential to shape the way we think about developmental systems and oncology.

摘要

时间调控的可变剪接选择对于正常发育至关重要,但错误的剪接选择可能有害。在这里,我们强调神经营养因子受体剪接变体TrkB.T1在人类和小鼠多种肿瘤类型的神经发育、胚胎发生、转化和肿瘤发生中一个以前未被识别的作用。TrkB.T1是整个胚胎器官发生过程中的主要异构体,在肿瘤抑制因子缺失的情况下,这种胚胎模式的强制过表达会在小鼠中导致多种实体瘤和非实体瘤。TrkB.T1还成为在多种成人和儿童肿瘤中表达的主要异构体,包括那些含有原肌球蛋白受体激酶融合的肿瘤。亲和纯化-质谱蛋白质组学分析揭示了与已知发育和致癌信号通路(如Wnt、转化生长因子-β、音猬因子和Ras)不同的相互作用分子。从剪接因子的改变到基因表达的变化,具有胚胎起源的异构体特异性癌基因的发现有可能改变我们对发育系统和肿瘤学的思考方式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8684/9544329/ee1d9a79d526/sciadv.abo6789-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8684/9544329/7fd37219eb7d/sciadv.abo6789-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8684/9544329/edf0439f6a3a/sciadv.abo6789-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8684/9544329/3887b515d3e6/sciadv.abo6789-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8684/9544329/aedf2654d63d/sciadv.abo6789-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8684/9544329/4bcd7af314fa/sciadv.abo6789-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8684/9544329/ee1d9a79d526/sciadv.abo6789-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8684/9544329/7fd37219eb7d/sciadv.abo6789-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8684/9544329/edf0439f6a3a/sciadv.abo6789-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8684/9544329/3887b515d3e6/sciadv.abo6789-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8684/9544329/aedf2654d63d/sciadv.abo6789-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8684/9544329/4bcd7af314fa/sciadv.abo6789-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8684/9544329/ee1d9a79d526/sciadv.abo6789-f6.jpg

相似文献

1
Oncogenic role of a developmentally regulated splice variant.一种发育调控剪接变体的致癌作用。
Sci Adv. 2022 Oct 7;8(40):eabo6789. doi: 10.1126/sciadv.abo6789.
2
A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways.激酶缺陷型 NTRK2 剪接变异体在神经胶质瘤中占优势,并扩增多个致癌信号通路。
Nat Commun. 2020 Jun 12;11(1):2977. doi: 10.1038/s41467-020-16786-5.
3
A subtype of oral, laryngeal, esophageal, and lung, squamous cell carcinoma with high levels of TrkB-T1 neurotrophin receptor mRNA.一种口腔、喉部、食管和肺部鳞状细胞癌的亚型,具有高水平的 TrkB-T1 神经营养因子受体 mRNA。
BMC Cancer. 2019 Jun 20;19(1):607. doi: 10.1186/s12885-019-5789-8.
4
Inhibiting TRK Proteins in Clinical Cancer Therapy.在临床癌症治疗中抑制TRK蛋白
Cancers (Basel). 2018 Apr 4;10(4):105. doi: 10.3390/cancers10040105.
5
Investigation of neurotrophic tyrosine kinase receptor 1 fusions and neurotrophic tyrosine kinase receptor family expression in non-small-cell lung cancer and sensitivity to AZD7451 .非小细胞肺癌中神经营养性酪氨酸激酶受体1融合及神经营养性酪氨酸激酶受体家族表达情况与对AZD7451敏感性的研究
Mol Clin Oncol. 2014 Sep;2(5):725-730. doi: 10.3892/mco.2014.318. Epub 2014 Jun 19.
6
Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for fusion cancers.用于融合癌的小分子原肌球蛋白受体激酶(TRK)抑制剂的研发。
Acta Pharm Sin B. 2021 Feb;11(2):355-372. doi: 10.1016/j.apsb.2020.05.004. Epub 2020 May 23.
7
Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy.检测肿瘤 NTRK 基因融合,以确定可能从酪氨酸激酶(TRK)抑制剂治疗中获益的患者。
J Mol Diagn. 2019 Jul;21(4):553-571. doi: 10.1016/j.jmoldx.2019.03.008. Epub 2019 May 7.
8
gene fusions as novel targets of cancer therapy across multiple tumour types.基因融合作为多种肿瘤类型癌症治疗的新靶点。
ESMO Open. 2016 Mar 18;1(2):e000023. doi: 10.1136/esmoopen-2015-000023. eCollection 2016.
9
Targeting TRK family proteins in cancer.在癌症中靶向 TRK 家族蛋白。
Pharmacol Ther. 2017 May;173:58-66. doi: 10.1016/j.pharmthera.2017.02.006. Epub 2017 Feb 4.
10
NTRK point mutations and their functional consequences.神经营养酪氨酸激酶受体(NTRK)点突变及其功能后果。
Cancer Genet. 2022 Apr;262-263:5-15. doi: 10.1016/j.cancergen.2021.12.002. Epub 2021 Dec 16.

引用本文的文献

1
Characterizing resistant cellular states in nasopharyngeal carcinoma during EBV lytic induction.在EB病毒裂解诱导过程中表征鼻咽癌的耐药细胞状态。
Oncogene. 2025 Mar 25. doi: 10.1038/s41388-025-03341-z.
2
Transcriptomic landscape identifies two unrecognized ependymoma subtypes and novel pathways in medulloblastoma.转录组图谱鉴定出髓母细胞瘤中两种未被识别的室管膜瘤亚型和新途径。
bioRxiv. 2024 Oct 22:2024.10.21.619495. doi: 10.1101/2024.10.21.619495.
3
Inhibition of exosome biogenesis affects cell motility in heterogeneous sub-populations of paediatric-type diffuse high-grade gliomas.

本文引用的文献

1
Aberrant RNA Splicing in Cancer.癌症中的异常RNA剪接
Annu Rev Cancer Biol. 2019 Mar;3(1):167-185. doi: 10.1146/annurev-cancerbio-030617-050407. Epub 2018 Nov 28.
2
A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways.激酶缺陷型 NTRK2 剪接变异体在神经胶质瘤中占优势,并扩增多个致癌信号通路。
Nat Commun. 2020 Jun 12;11(1):2977. doi: 10.1038/s41467-020-16786-5.
3
() Alterations in Low-Grade Gliomas: Report of a Novel Gene Fusion Partner in a Pilocytic Astrocytoma and Review of the Literature.
外泌体生物发生的抑制影响儿童型弥漫性高级别胶质瘤异质亚群中的细胞运动。
Cell Biosci. 2023 Nov 13;13(1):207. doi: 10.1186/s13578-023-01166-5.
4
Revisiting the expression of BDNF and its receptors in mammalian development.重新审视脑源性神经营养因子(BDNF)及其受体在哺乳动物发育过程中的表达。
Front Mol Neurosci. 2023 Jun 22;16:1182499. doi: 10.3389/fnmol.2023.1182499. eCollection 2023.
()低级别胶质瘤的改变:一例毛细胞型星形细胞瘤中新型基因融合伙伴的报告及文献综述
Case Rep Pathol. 2020 Jan 30;2020:5903863. doi: 10.1155/2020/5903863. eCollection 2020.
4
The reactome pathway knowledgebase.Reactome 通路知识库。
Nucleic Acids Res. 2020 Jan 8;48(D1):D498-D503. doi: 10.1093/nar/gkz1031.
5
Detection of Fusions: Merits and Limitations of Current Diagnostic Platforms.融合基因检测:当前诊断平台的优缺点。
Cancer Res. 2019 Jul 1;79(13):3163-3168. doi: 10.1158/0008-5472.CAN-19-0372. Epub 2019 Jun 13.
6
Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.雌二醇诱导三阴性乳腺癌中的 BDNF/TrkB 信号转导以促进脑转移。
Oncogene. 2019 Jun;38(24):4685-4699. doi: 10.1038/s41388-019-0756-z. Epub 2019 Feb 22.
7
The single-cell transcriptional landscape of mammalian organogenesis.哺乳动物器官发生的单细胞转录组图谱。
Nature. 2019 Feb;566(7745):496-502. doi: 10.1038/s41586-019-0969-x. Epub 2019 Feb 20.
8
TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening.儿童中的 TRK 融合癌:临床综述及筛查建议。
J Clin Oncol. 2019 Feb 20;37(6):513-524. doi: 10.1200/JCO.18.00573. Epub 2018 Dec 28.
9
NTRK fusion-positive cancers and TRK inhibitor therapy.NTRK 融合阳性癌症和 TRK 抑制剂治疗。
Nat Rev Clin Oncol. 2018 Dec;15(12):731-747. doi: 10.1038/s41571-018-0113-0.
10
The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer.癌症剪接体:癌症中可变剪接的重编程
Front Mol Biosci. 2018 Sep 7;5:80. doi: 10.3389/fmolb.2018.00080. eCollection 2018.